APPLIED THERAPEUTICS INC (APLT)
US03828A1016 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.993M | 544.272K -94.55% | 15.045M 2,664.24% | 67.882M 351.19% | 70.804M 4.30% | 138.09M 95.03% | 239.03M 73.10% | 360.08M 50.64% | 481.12M 33.61% | |||
| EBITDA YoY % growth | N/A -14.57% | -82.95M 25.51% | N/A 28.78% | -96.898M -64.02% | -36.341M 62.50% | 39.469M 208.61% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -105.62M -11.80% | -82.95M 21.46% | -64.535M 22.20% | -100.155M -55.19% | -77.741M 22.38% | -8.108M 89.57% | -102.405M -1,163.05% | -59.068M 42.32% | 19.844M 133.60% | 124.04M 525.08% | 230.47M 85.80% | |
| Operating Margin | N/A | N/A | -645.80% | -18,401.57% | -516.72% | -11.94% | -144.63% | -42.78% | 8.30% | 34.45% | 47.90% | |
| EPS YoY % growth | -4.12 3.06% | -2.24 45.63% | -1.36 39.29% | -1.49 -9.60% | -0.54 63.79% | -0.28 47.47% | -0.54 -90.65% | -0.36 33.96% | 0.10 128.57% | 0.65 540.00% | 0.99 51.56% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 48.76% | -0.12 82.75% | -0.17 -932.98% | -0.12 74.50% | -0.08 51.21% | -0.05 55.88% | 0.03 118.37% | 0.08 166.67% | 0.14 268.01% |
| Revenue Q2Q % growth | 846.6K 226.93% | 16.449M 8,557.37% | 11.213M 7,686.81% | 18.163M 14,787.70% | 27.156M 3,107.65% | 29.417M 78.84% | 44.135M 293.61% | 59.129M 225.55% | 74.429M 174.08% |
| EBITDA Q2Q % growth | -19.324M -18.34% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.874M 58.36% | -12.271M 41.82% | -23.726M -16.07% | -17.898M 39.82% | -11.211M 58.28% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.48 -2.13% | -0.16 | -0.32 | -197.84% |
| Q2 2024 Q2Q % growth | 0.02 105.41% | -0.17 | 0.19 | 111.97% |
| Q1 2024 Q2Q % growth | -0.67 -272.22% | -0.16 | -0.51 | -311.83% |
| Q4 2023 Q2Q % growth | -0.34 -112.50% | -0.23 | -0.11 | -46.20% |
| Q3 2023 Q2Q % growth | -0.47 -17.50% | -0.26 | -0.21 | -77.68% |
| Q2 2023 Q2Q % growth | -0.37 53.75% | -0.27 | -0.10 | -36.88% |
| Q1 2023 Q2Q % growth | -0.18 79.55% | -0.31 | 0.13 | 42.42% |
| Q4 2022 Q2Q % growth | -0.16 84.62% | -0.47 | 0.31 | 66.07% |
| Q3 2022 Q2Q % growth | -0.40 63.30% | -0.49 | 0.09 | 17.89% |
| Q2 2022 Q2Q % growth | -0.80 19.19% | -0.80 | 0.00 | 0.06% |
| Q1 2022 Q2Q % growth | -0.88 12.00% | -0.85 | -0.03 | -3.50% |
| Q4 2021 Q2Q % growth | -1.04 1.89% | -1.27 | 0.23 | 18.25% |
| Q3 2021 Q2Q % growth | -1.09 18.05% | -1.19 | 0.10 | 8.16% |
| Q2 2021 Q2Q % growth | -0.99 22.05% | -1.15 | 0.16 | 14.12% |
| Q1 2021 Q2Q % growth | -1.00 -69.49% | -1.03 | 0.03 | 2.64% |
| Q4 2020 Q2Q % growth | -1.06 32.48% | -1.28 | 0.22 | 16.93% |
| Q3 2020 Q2Q % growth | -1.33 -111.11% | -1.04 | -0.29 | -28.23% |
| Q2 2020 Q2Q % growth | -1.27 -111.67% | -0.70 | -0.57 | -81.08% |
| Q1 2020 Q2Q % growth | -0.59 62.66% | -0.83 | 0.24 | 29.34% |
| Q4 2019 Q2Q % growth | -1.57 | -0.66 | -0.91 | -138.86% |
| Q3 2019 Q2Q % growth | -0.63 | -0.50 | -0.13 | -24.95% |
| Q2 2019 Q2Q % growth | -0.60 | -0.50 | -0.10 | -19.14% |
| Q1 2019 Q2Q % growth | -1.58 | -0.41 | -1.17 | -282.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 144K | 2.55M | -2.406M | -94.35% |
| Q1 2024 Q2Q % growth | 190K -98.22% | 3.4M | -3.21M | -94.41% |
| Q2 2023 Q2Q % growth | 8.16M | -8.16M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 21.17% | -9.61% | -52.62% |
| Revenue | 0% | -52.99% | -59.23% | -68.63% |